Related Experiment Video
Updated: May 10, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
Kidney disease in children and adolescents with perinatal HIV-1 infection
Rajendra Bhimma1, Murli Udharam Purswani, Udai Kala
1Department of Paediatrics and Child Health, School of Clinical Medicine, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa. bhimma@ukzn.ac.za
Insights
Highly active anti-retroviral therapy (HAART) has improved outcomes for children with HIV-1 kidney disease, particularly HIV-associated nephropathy (HIVAN). However, other kidney issues and drug toxicities require ongoing attention and research.
Area of Science:
- Pediatric Nephrology
- Infectious Diseases
- HIV/AIDS Research
Background:
- Children with perinatal HIV-1 infection face diverse kidney issues, including acute kidney injury, UTIs, electrolyte imbalances, nephrotoxicity, and glomerular diseases.
- HIV-associated nephropathy (HIVAN) was a common cause of chronic kidney disease (CKD) in these children, often leading to end-stage kidney disease.
Purpose of the Study:
- To review the pathogenesis, genetics, clinical presentation, and management of kidney diseases in children and adolescents with perinatal HIV-1 infection.
- To highlight the impact of highly active anti-retroviral therapy (HAART) on HIV-associated kidney disease outcomes.
- To discuss current and future strategies for screening, prevention, and treatment of kidney disease in this population.
Main Methods:
- Literature review focusing on pathogenesis, genetics, clinical presentation, and management.
- Analysis of the impact of HAART on HIV-associated nephropathy (HIVAN) and other kidney diseases.
- Evaluation of renal replacement therapies including hemodialysis, peritoneal dialysis, and kidney transplantation.
Main Results:
- HAART has significantly reduced HIVAN incidence and improved prognosis, allowing long-term survival.
- The impact of HAART on other kidney diseases and drug-induced nephrotoxicity is less pronounced.
- Both hemodialysis and peritoneal dialysis are effective renal replacement therapies, with peritoneal dialysis favored in resource-limited settings.
Conclusions:
- Understanding the molecular pathogenesis and genetics of HIV-related kidney disease is crucial for improved care.
- Kidney transplantation is now a viable and effective renal replacement therapy for selected HIV-infected patients.
- Routine kidney disease screening is recommended for HIV-infected children and adolescents where resources permit.
Introduction:
Involvement of the kidney in children and adolescents with perinatal (HIV-1) infection can occur at any stage during the child's life with diverse diagnoses, ranging from acute kidney injury, childhood urinary tract infections (UTIs), electrolyte imbalances and drug-induced nephrotoxicity, to diseases of the glomerulus. The latter include various immune-mediated chronic kidney diseases (CKD) and HIV-associated nephropathy (HIVAN).
Discussion:
The introduction of highly active anti-retroviral therapy (HAART) has dramatically reduced the incidence of HIVAN, once the commonest form of CKD in children of African descent living with HIV, and also altered its prognosis from eventual progression to end-stage kidney disease to one that is compatible with long-term survival. The impact of HAART on the outcome of other forms of kidney diseases seen in this population has not been as impressive. Increasingly important is nephrotoxicity secondary to the prolonged use of anti-retroviral agents, and the occurrence of co-morbid kidney disease unrelated to HIV infection or its treatment. Improved understanding of the molecular pathogenesis and genetics of kidney diseases associated with HIV will result in better screening, prevention and treatment efforts, as HIV specialists and nephrologists coordinate clinical care of these patients. Both haemodialysis (HD) and peritoneal dialysis (PD) are effective as renal replacement therapy in HIV-infected patients with end-stage kidney disease, with PD being preferred in resource-limited settings. Kidney transplantation, once contraindicated in this population, has now become the most effective renal replacement therapy, provided rigorous criteria are met. Given the attendant morbidity and mortality in HIV-infected children and adolescents with kidney disease, routine screening for kidney disease is recommended where resources permit.
Conclusions:
This review focuses on the pathogenesis and genetics, clinical presentation and management of kidney disease in children and adolescents with perinatal HIV-1 infection.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Kidney Transplant I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
